NicOx Completes $44.92M Fundraising as FDA Accepts NDA for Osteoarthritis Drug

The fundraising included a €20 million (about $29.95 million) cornerstone investment by Fonds Stratégique d'Investissement (FSI), which as a result now owns ...
See all stories on this topic

Leave a reply

Security Code:

© 2010 - Your Company Name